Sign In
Buy CYTK
$80.01
+0.84 (+1.06%)
At Close: Jun 23, 2026
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Tuesday, 10'th Nov 2020
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on October 30, 2020 it granted stock options to purchase an aggregate of 2
Primary Results from GALACTIC-HF to be Presented in Late Breaking Clinical Trial Session
Cytokinetics, Inc. (CYTK) CEO Robert Blum on Q3 2020 Results - Earnings Call Transcript
10:49pm, Wednesday, 04'th Nov 2020
Cytokinetics, Inc. (CYTK) CEO Robert Blum on Q3 2020 Results - Earnings Call Transcript
Biogen: Neurology Leader Pivots To Gene Therapy (NASDAQ:BIIB)
12:24am, Tuesday, 20'th Oct 2020
Biogen has embraced Ionis antisense technology for neurology targets. A new Gene Therapy Accelerator Unit was formed last year and has facilitated the creation of new business units and collaborations
Sanders Morris Harris LLC Invests $413,000 in Cytokinetics, Inc. (NASDAQ:CYTK)
06:36am, Monday, 19'th Oct 2020
Sanders Morris Harris LLC bought a new position in shares of Cytokinetics, Inc. (NASDAQ:CYTK) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Co
$3.80 Million in Sales Expected for Cytokinetics, Inc. (NASDAQ:CYTK) This Quarter
04:46am, Sunday, 18'th Oct 2020
Equities analysts expect Cytokinetics, Inc. (NASDAQ:CYTK) to post $3.80 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Cy
Robert I. Blum Sells 5,000 Shares of Cytokinetics, Inc. (NASDAQ:CYTK) Stock
07:04am, Friday, 16'th Oct 2020
Cytokinetics, Inc. (NASDAQ:CYTK) CEO Robert I. Blum sold 5,000 shares of the firm’s stock in a transaction on Tuesday, October 13th. The stock was sold at an average price of $15.94, for a total val
Fady Ibraham Malik Sells 1,258 Shares of Cytokinetics, Inc. (NASDAQ:CYTK) Stock
07:10am, Saturday, 10'th Oct 2020
Cytokinetics, Inc. (NASDAQ:CYTK) EVP Fady Ibraham Malik sold 1,258 shares of the stock in a transaction dated Thursday, October 8th. The shares were sold at an average price of $17.45, for a total tra
BidaskClub Upgrades Cytokinetics (NASDAQ:CYTK) to “Buy”
10:27am, Friday, 09'th Oct 2020
Cytokinetics (NASDAQ:CYTK) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a note issued to investors on Wednesday, BidAskClub reports. A number of ot
THOUSAND OAKS, Kalifornien / SOUTH SAN FRANCISCO, Kalifornien / SURESNES, Frankreich (ots) - - Studie erreicht primären kombinierten Endpunkt der Reduktion von kardiovaskulären Todesfällen oder …
Amgen and Cytokinetics Stock Slide After Heart Drug Trial Results
08:13pm, Thursday, 08'th Oct 2020
The pivotal trial of a heart failure drug achieved its endpoint with statistical significance, the developers said. But investors were still concerned.
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, Oct. 8, 2020 /PRNewswire via COMTEX/ --
THOUSAND OAKS, Calif. and SOUTH SAN...
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France, Oct 08, 2020 (GLOBE NEWSWIRE via COMTEX) --
Trial Met Primary Composite Endpoint...
